Renal sympathetic denervation

PROCEDURE15 trials

Sponsors

University Hospital of North Norway, The First Affiliated Hospital with Nanjing Medical University, Royal Brompton & Harefield NHS Foundation Trust, UMC Utrecht, Vivek Reddy

Conditions

Aorticorenal GanglionArterial HypertensionAtrial FibrillationAutonomic RegulationAutosomal Dominant Polycystic Kidney DiseaseCardiac FailureChronic Kidney DiseaseHypertensie High blood pressure hypertension

Phase 2

Renal Denervation in Heart Failure With Preserved Ejection Fraction

CompletedNCT01840059

Royal Brompton & Harefield NHS Foundation TrustCardiac Failure

Start: 2013-04-30End: 2015-09-30Updated: 2015-09-15

Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control

Mei changlinAutosomal Dominant Polycystic Kidney Disease, Hypertension

Start: 2013-08-31End: 2015-07-31Target: 100Updated: 2014-09-25

Phase 3

Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension

CompletedNCT01850901

UMC UtrechtChronic Kidney Disease, Hypertension

Start: 2013-05-31End: 2016-12-31Updated: 2017-02-01

Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation

CompletedNCT01873352

Meshalkin Research Institute of Pathology of CirculationAtrial Fibrillation, Hypertension

Start: 2013-06-20End: 2019-03-01Updated: 2019-09-04

Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension

Seoul St. Mary's HospitalHypertension

Start: 2014-09-30End: 2018-10-31Target: 40Updated: 2015-01-26

Unknown Phase

Renal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors

CompletedNCT01630928

University Hospital of North NorwayHypertension, Resistant to Conventional Therapy

Start: 2013-03-31End: 2015-12-31Updated: 2016-05-16

Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation

The First Affiliated Hospital with Nanjing Medical UniversityAtrial Fibrillation, Hypertension

Start: 2012-07-31End: 2015-07-31Target: 200Updated: 2013-07-08

Renal Sympathetic Denervation in Patients With Hypertension and Paroxysmal Atrial Fibrillation

The First Affiliated Hospital with Nanjing Medical UniversityAtrial Fibrillation, Hypertension

Start: 2012-07-31End: 2015-06-30Target: 100Updated: 2013-03-19

REnal Sympathetic dEnervaTion as an a Adjunct to Catheter-based VT Ablation

CompletedNCT01858194

Vivek ReddyVentricular Tachycardia

Start: 2013-03-31End: 2017-09-01Updated: 2020-04-17

Renal Sympathetic Denervation From The Adventitia on Hypertension

CompletedNCT02642445

Henan Institute of Cardiovascular EpidemiologyPrimary Aldosteronism Due to Aldosterone Producing Adenoma

Start: 2016-12-31End: 2019-12-31Updated: 2020-11-03

Renal Sympathetic Denervation in Moderate to Severe Chronic Kidney Disease

CompletedNCT02863510

Heart of England NHS TrustChronic Kidney Disease, Hypertension

Start: 2013-09-30End: 2016-07-31Updated: 2017-08-09

ConfidenHTTM system safety and performance of diagnostic electrical mapping of renal nerves in hypertensive patients and/or potential candidates for a renal sympathetic denervation (RDN) procedure

Active, not recruitingNL-OMON43150

Pythagoras Medical Ltd.Hypertensie High blood pressure hypertension

Start: 2016-10-19Target: 10Updated: 2024-02-28

Systemic Microvascular Function in Patients With Resistant Hypertension After Renal Sympathetic Denervation

CompletedNCT03243045

National Institute of Cardiology, Laranjeiras, BrazilArterial Hypertension, Resistant Arterial Hypertension

Start: 2017-03-01End: 2020-01-06Updated: 2020-01-07

Prediction of Blood Pressure Outcomes Following Renal Denervation (PREDICT-RDN)

RecruitingNCT06845579

Heart Center Leipzig - University HospitalUncontrolled Arterial Hypertension

Start: 2025-06-01End: 2028-02-29Target: 90Updated: 2025-06-24

Renal Sympathetic Denervation Combined With Aorticorenal Ganglion Ablation for Treatment of Hypertension

WithdrawnNCT06864962

The Second Affiliated Hospital of Chongqing Medical UniversityAorticorenal Ganglion, Autonomic Regulation, Hypertension +1

Start: 2025-03-31End: 2026-01-31Updated: 2025-05-14

Related Papers

Quality of life following renal sympathetic denervation in treatment-resistant hypertensive patients: a two-year follow-up study

Scandinavian Cardiovascular Journal2022-06-103 citations

Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension

JAMA2020-01-21209 citations

Impact of Medication Adherence on the Effect of Renal Denervation

Hypertension2017-03-0782 citations

Renal sympathetic denervation versus antiarrhythmic drugs for drug-resistant hypertension and symptomatic atrial fibrillation (RSDforAF) trial: study protocol for a randomized controlled trial.

2013-06-118 citations